Articles tagged with Gene Patents
Dan Devers joins the Stowers Institute with over 20 years of experience in law and business. He will lead all legal matters across the Institute, ensuring governance, compliance, intellectual property strategy, and partnerships support the Institute's mission to diagnose, treat, and prevent disease.
Engineered cell lines are prone to misidentification, threatening scientific discoveries and intellectual property. Researchers at UT Dallas have developed a novel method to embed unique genetic identifiers, eliminating identification errors and safeguarding innovations with tamper-proof genomic tags.
Researchers at the University of Sydney developed a biological 'artificial intelligence' system called PROTEUS, which can accelerate cycles of evolution and natural selection to create molecules with new functions in weeks. The system has potential applications in finding new medicines and improving gene editing technology like CRISPR.
A West Virginia University legal scholar argues that current laws favor biologic drugs with longer exclusivity periods, affecting their pricing. The scholar suggests reducing exclusivity for biologics to bring them in line with small-molecule drugs, which could lower drug costs.
A research team from Tokyo University of Science has developed a new method to create copolymers with different metal species, which have potential uses in catalysis and drug discovery. The technique allows for controlling the composition of metal species in the resulting polymer.
Researchers from Kazan Federal University have developed a gene-cell preparation that uses membrane vesicles to target and kill cancer cells. The technology has shown promise in treating various types of cancer, including breast, lung, and colon cancer.
A new diagnostic system was developed by Lithuanian scientists, achieving over 90% accuracy in detecting melanoma from skin lesions. The non-invasive method combines data from optical spectrophotometry and ultrasound imaging technologies.
A new study found that academic scientists prioritize social impact and intellectual challenge over financial gain when engaging in commercial activities. In life sciences, a strong desire for social impact drives patent applications, while engineers are motivated by intellectual challenge and peer recognition.
A team of scientists from Purdue University and international research institutions developed a new method for identifying nonviral vectors in gene therapies. This approach uses big data, patent, and clinical data mining to uncover emerging trends in the field. The study aims to guide future developments in gene therapy.
Prophetic patents often describe hypothetical experiments with excessive detail, potentially misleading scientists and non-experts. Labels are suggested to distinguish between prophetic and non-prophetic examples in patent applications.
The Open Source Seed Licence safeguards plant germplasm by protecting it from patenting and exclusive rights. This allows for the free exchange of breeding material and knowledge, enabling the development of new varieties like 'Sunviva', a cherry tomato well-suited for gardens and balconies.
A single transnational corporation has registered 47% of marine genetic sequences, while entities in only 10 countries account for 98% of patents. The study highlights the need for a legal framework to regulate access and use of marine genetic resources beyond national jurisdiction.
Researchers have developed virus-derived expression vectors as a potential gene therapy vehicle for treating various diseases. These vectors use viral sequences to silence specific genes or induce RNA interference, effectively downregulating viral replication and expressing therapeutic proteins.
The patented resin is made from plant oils, offering a sustainable alternative to traditional adhesives. It provides improved water-resistance, shelf life, and adhesion, making it suitable for various applications, including labeling and coatings.
A US patent has been granted to Oregon researchers for their fractal-based approach to electronic implants that match up with specific neurons. The technology, developed by University of Oregon physicist Richard Taylor, aims to overcome biological rejection issues and toxicity concerns in current implant designs.
University of Houston faculty members Allan Jacobson and Richard Willson have been named fellows of the National Academy of Inventors for their work on lithium batteries, catalysts, and nanotechnology. They are recognized for their innovations in areas such as patents and licensing, innovative discovery, and significant impact on society.
A new paper from Rice University's Baker Institute calls for revised patenting guidelines to address the broad patent landscape in biotechnology. The authors suggest initial steps to reform patent licensing and require detailed patent descriptions to prevent costly lawsuits.
Dr. Frederic Zenhausern has been inducted into the Fellows of the National Academy of Inventors for his rapid DNA processing innovations that contribute to Arizona's economic development. His work is aimed at early diagnostics of human diseases, with a focus on integrating bioassay chemistries and biomarkers.
A new public resource, The Lens, brings transparency to gene patenting by analyzing over 120 million DNA sequences and 10 million protein sequences from global patent documents. Researchers can explore who has sought patents on genes and proteins in any organism, promoting a transparent and fair society.
A CSIC study reveals that Japan, China, and South Korea account for 84% of macroalgae patents, highlighting the importance of scientific investment in biotechnology development. The study also suggests that under-invested Asian nations are missing out on market opportunities due to low research efforts.
A recent study reveals that 41% of the human genome is covered by longer DNA patents, which could lead to a loss of individual genomic liberty. The study also found that short sequences from patents cover virtually the entire genome, even outside of genes.
The oceans' untapped genetic resources hold huge potential for medicines, foods, and biofuels. International agreements are required to ensure equal benefits from these resources. Developing countries need support in participating in research and invention.
Xiaohong Wang's diagnostic test can identify the type of nematode infesting a field, crucial for developing resistant potato varieties. The test is 1000 times more sensitive than traditional methods, enabling reliable results from small amounts of nematode material.
A team of scholars calls for collective action to address the negative effects of patenting and privatizing stem cell lines, data, and technologies. The experts warn that the lack of transparency and ambiguity in ownership and control can hinder progress toward breakthroughs.
Exclusive licenses to gene patents hinder competition and innovation in genetic testing, according to researchers at the Duke Institute for Genome Sciences & Policy. The findings suggest that overly broad patent claims are the primary issue, rather than patents themselves.
Researchers from Duke University found that exclusive patents in gene testing slow promising new technologies and business models. The studies examined genetic risk testing for 10 clinical conditions, including breast and colon cancer.
The ACLU is challenging the patentability of two human genes linked to breast and ovarian cancer, alleging that gene patents stifle life science research. The organization claims that the patents are invalid and unconstitutional, with supporters arguing that they would harm patients and limit medical research.
A systematic review found that screening all women with newly diagnosed breast cancer using immunohistochemistry and confirming ambiguous results with fluorescence in situ hybridization is the most cost-effective strategy. Gene patenting can lead to restricted access to genetic testing and treatments, increasing healthcare costs.
Dutch researchers have developed a DNA layer that improves attachment, recovery, and immune response to body implants. The coating, patented by Jeroen van den Beucken, approximates the body's natural material, reducing inflammation and immune responses.
The BiOS Initiative aims to develop inclusive technology toolkits by mapping patent landscapes and fostering collaboration among scientists, farmers, and innovators. This effort seeks to provide better problem-solving options for developing countries, prioritizing local needs and independence.
Jim Hutchison's new patent may lead to the development of ultrasmall transistors that operate efficiently at room temperature, revolutionizing electronics and optics. The nanoscale transistors are composed of nanoparticle building blocks and function based on a mix of classical and quantum mechanical properties.
The UN University report highlights concerns over unregulated bioprospecting in Antarctica, threatening environmental consequences and ownership disputes. Despite the potential for breakthroughs in cancer treatment and industrial compounds, efforts to exploit extremophiles need international regulation.
The field of operations research has a significant impact on the development of medical and telecom innovations, with 24,637 patents referencing optimization techniques between 1996-2001. The study highlights the use of simulation and queue management as critical components in inventions.
The Lancet neurology reviews research on migraine genetics, highlighting the challenges of identifying genes involved in the disorder. The article also examines the implications of private diagnostic testing without physician support, sparking debate about its role in advancing treatment options for neurological diseases.
Roy Curtiss III's patent covers a genetically engineered bacterial antigen delivery system that induces immune responses against foreign antigens. The technology is being used to develop recombinant vaccines for various pathogens, including Heliobacter pylori and Mycobacterium tuberculosis.